Public Consultations are held regularly as a form of soliciting public input on the draft documents produced by EUnetHTA within the framework of implementing the EUnetHTA Joint Action 2 grant agreement and 3-year EUnetHTA Joint Action 2 Work Plan. Announcements of the public consultations are made in the News section of this website.

Properly submitted contributions will be made public on the EUnetHTA public website within a month after the closing date of the public consultation (unless the author has explicitly opposed publication of their contribution or the contributions do not address the draft documents put forward for public consultation or contain complaints against institutions, personal accusations, irrelevant or offensive statements or material). The name of the author, his affiliation, and date of the submission’s receipt will be disclosed when the contribution is made public.

More detailed instructions are provided on the news dedicated for each specific public consultation.

We are pleased to announce that as of today, 11 June, 2014, the draft methodological guideline “Meta-analysis of diagnostic test accuracy studies”, produced within WP7 - Subgroup 3, has entered the public consultation phase.
We are pleased to announce that as of today, 19 May, 2014, the Draft Project Plan on “Balloon Eustachian tuboplasty for the treatment of Eustachian tube dysfunction”, produced within WP5 Strand B, has entered the public consultation phase.
We are pleased to announce that as of today, 12 May 2014, the Draft Project Plan on “Biodegradable stents for benign refractory esophageal stenosis” produced within WP5 Strand B, has entered the public consultation phase.
We are happy to announce that the first Core HTA produced within the EUnetHTA Joint Action 2 Work Package 4 is available for public feedback. The topic assessed is “Fecal Immunochemical Test (FIT) versus guaiac-based fecal occult blood test (FOBT) for colorectal cancer screening”
Public consultation of the Draft Project Plan on “Renal sympathetic denervation (Symplicity®) for the treatment of resistant arterial hypertension”. We are pleased to announce that as of today the Draft Project Plan on “Renal sympathetic denervation (Symplicity®) for the treatment of resistant arterial hypertension”, produced within WP5 Strand B, has entered the public consultation phase.